Interleukin-1 promotion of MAPK-p38 overexpression in experimental animalsand in Alzheimer's disease: potential significance for tau protein phosphorylation
Jg. Sheng et al., Interleukin-1 promotion of MAPK-p38 overexpression in experimental animalsand in Alzheimer's disease: potential significance for tau protein phosphorylation, NEUROCHEM I, 39(5-6), 2001, pp. 341-348
Activated (phosphorylated) mitogen-activated protein kinase p38 (MAPK-p38)
and interleukin-1 (IL-1) have both been implicated in the hyperphosphorylat
ion of tau, a major component of the neurofibrillary tangles in Alzheimer's
disease. This, together with findings showing that IL-1 activates MAPK-p38
in vitro and is markedly overexpressed in Alzheimer brain, suggest a role
for IL-1-induced MAPK-p38 activation in the genesis of neurofibrillary path
ology in Alzheimer's disease, We found frequent colocalization of hyperphos
phorylated tau protein (AT8 antibody) and activated MAPK-p38 in neurons and
in dystrophic neurites in Alzheimer brain. and frequent association of the
se structures with activated microglia overexpressing IL-1. Tissue levels o
f IL-1 mRNA as well as of both phosphorylated and non-phosphorylated isofor
ms of tau were elevated in these brains. Significant correlations were foun
d between the numbers of AT8- and MAPK-p38-immunoreactive neurons, and betw
een the numbers of activated microglia overexpressing IL-1 and the numbers
of both AT8- and MAPK-p38-immunoreactive neurons. Furthermore, rats bearing
IL-1-impregnated pellets showed a six- to seven-fold increase in the level
s of MAPK-p38 mRNA, compared with rats with vehicle-only pellets (P < 0.000
1). These results suggest that microglial activation and IL-1 overexpressio
n are part of a feedback cascade in which MAPK-p38 overexpression and activ
ation leads to tau hyperphosphorylation and neurofibrillary pathology in Al
zheimer's disease. (C) 2001 Published by Elsevier Science Ltd.